C1q Binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14–26 of the human C1qA chain in a sequence independent manner-Reference-Cited by-同舟云学术

C1q Binding to liposomes is surface charge dependent and is inhibited by peptides consisting of residues 14–26 of the human C1qA chain in a sequence independent manner

Published:1999-04 Issue:1 Volume:1418 Page:19-30
ISSN:0005-2736
Container-title:Biochimica et Biophysica Acta (BBA) - Biomembranes
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Biomembranes

Author:

Bradley Amanda J,Brooks Donald E,Norris-Jones Raymond,Devine Dana V

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry,Biophysics

Reference38 articles.

1. Sterically stabilized liposomes;Woodle;Biochim. Biophys. Acta,1992

2. Association of blood proteins with large unilamellar liposomes in vivo;Chonn;J. Biol. Chem.,1992

3. Opsonophagocytosis of liposomes by peritoneal macrophages and bone marrow reticuloendothelial cells;Moghimi;Biochim. Biophys. Acta,1992

4. The complement system in liposome clearance: can complement deposition be inhibited?;Devine;Adv. Drug Deliv. Rev.,1998

5. Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat plasma;Funato;Biochim. Biophys. Acta,1992

Cited by 153 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing siRNA cancer therapy: Multifaceted strategies with lipid and polymer-based carrier systems;International Journal of Pharmaceutics;2024-09

2. Activation of the complement system by nanoparticles and strategies for complement inhibition;European Journal of Pharmaceutics and Biopharmaceutics;2023-12

3. A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics;Advanced Drug Delivery Reviews;2023-10

4. Polymeric Nanoparticles and Nanogels: How Do They Interact with Proteins?;Gels;2023-08-06

5. From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics;Pharmaceuticals;2023-07-31